Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:disease incidence/prevalence measurement
go back to main search page
Accession:CMO:0000926 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display a disease at a point in time or develop a disease within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.
Comment:Epidemiologically, incidence specifically refers to "the rate at which a certain event occurs, as the number of new cases of a specific disease occurring during a certain period in a population at risk" (Dorland), but in popular usage it can also be used as a measure of the number of individuals in a population which have a particular condition, i.e. as a synonym for prevalence.



show annotations for term's descendants           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    disease population measurement 0
      disease incidence/prevalence measurement 0
        alimentary/gastrointestinal disease incidence/prevalence measurement + 0
        arthritis incidence/prevalence measurement + 0
        cataract incidence/prevalence measurement + 0
        chronic pancreatitis incidence/prevalence measurement + 0
        congenital malformation incidence/prevalence measurement + 0
        diabetes mellitus incidence/prevalence measurement + 0
        endometrioid carcinoma incidence/prevalence measurement + 0
        glycosuria incidence/prevalence measurement + 0
        hematuria incidence/prevalence measurement + 0
        infection incidence/prevalence measurement + 0
        leukemia incidence/prevalence measurement + 0
        lymphoma incidence/prevalence measurement + 0
        nervous system disease incidence/prevalence measurement + 0
        organ non-tumorous lesion incidence/prevalence measurement + 0
        organ tumorous lesion incidence/prevalence measurement + 0
        percentage of study population developing ascites during a period of time 0
        percentage of study population developing extra-hepatic metastases during a period of time 0
        percentage of study population developing peritoneal carcinomatosis during a period of time 0
        percentage of study population developing radiation pneumonitis during a period of time 0
        percentage of study population developing radiation-induced bone marrow disease during a period of time 0
        pyometritis incidence/prevalence measurement + 0
        retinopathy incidence/prevalence measurement + 0
paths to the root